Chari, A., Rodriguez‐Otero, P., McCarthy, H., Suzuki, K., Hungria, V., Sureda Balari, A., Perrot, A., Hulin, C., Magen, H., Iida, S., Maisnar, V., Karlin, L., Pour, L., Parasrampuria, D. A., Masterson, T., Kosh, M., Yang, S., Delioukina, M., Qi, M., Carson, R., & Touzeau, C. (2021). subcutaneous daratumumab plus standard treatment regimens in patients with multiple myeloma across lines of therapy (PLEIADES): an open‐label Phase II study. British journal of haematology, 192, 869–878. http://access.bl.uk/ark:/81055/vdc_100122327380.0x00005c